Omada Hypertension Program for Hypertension

Phase-Based Progress Estimates
Stanford University, Redwood City, CA
Omada Hypertension Program - Other
All Sexes
What conditions do you have?

Study Summary

High blood pressure, also known as hypertension, affects nearly half of all Americans and increases the risk for heart disease and stroke. Only about half of people with high blood pressure have it under control. New methods to control blood pressure are needed to reduce heart attack and stroke rates. The purpose of this study is to test whether a digital program that includes personalized health coaching and remote patient monitoring with a connected blood pressure cuff, all delivered on a smartphone or website, can improve blood pressure control compared with usual care among patients with high blood pressure.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Hypertension

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: Baseline, 1 year

Baseline, 1 year
Mean change from baseline in A1c at 1-year
Mean change from baseline in systolic blood pressure at 1-year
Mean change from baseline in weight at 1-year

Trial Safety

Safety Progress

1 of 3

Other trials for Hypertension

Trial Design

2 Treatment Groups

Does not receive access to Omada Health program
1 of 2
Receives access to Omada Health program
1 of 2
Active Control
Experimental Treatment

550 Total Participants · 2 Treatment Groups

Primary Treatment: Omada Hypertension Program · No Placebo Group · N/A

Receives access to Omada Health program
Experimental Group · 1 Intervention: Omada Hypertension Program · Intervention Types: Other
Does not receive access to Omada Health programNoIntervention Group · 1 Intervention: Does not receive access to Omada Health program · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 1 year
Closest Location: Stanford University · Redwood City, CA
Photo of Stanford University 1Photo of Stanford University 2Photo of Stanford University 3
1992First Recorded Clinical Trial
24 TrialsResearching Hypertension
768 CompletedClinical Trials

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,130 Previous Clinical Trials
35,668,360 Total Patients Enrolled
30 Trials studying Hypertension
48,263 Patients Enrolled for Hypertension
Omada Health, Inc.Industry Sponsor
4 Previous Clinical Trials
1,052 Total Patients Enrolled
Steven Lin, MDPrincipal InvestigatorStanford University

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are at least 18 years old.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.